Author Correction: Intravenous and intracranial GD2-CAR T cells for H3K27M⁺ diffuse midline gliomas

Michelle Monje^{1

2

3

4

5

6}, Jasia Mahdi^{7

8}, Robbie Majzner^{9

8}, Kristen W Yeom^{7

10

11}, Liora M Schultz^{9

8}, Rebecca M Richards^{9

8}, Valentin Barsan^{9

8}, Kun-Wei Song^{7

8}, Jen Kamens^{9

8}, Christina Baggott⁸, Michael Kunicki⁸, Skyler P Rietberg⁸, Alexandria Sung Lim⁸, Agnes Reschke^{9

8}, Sharon Mavroukakis⁸, Emily Egeler⁸, Jennifer Moon⁸, Shabnum Patel⁸, Harshini Chinnasamy⁸, Courtney Erickson⁸, Ashley Jacobs⁸, Allison K Duh¹⁰, Ramya Tunuguntla⁸, Dorota Danuta Klysz⁸, Carley Fowler⁸, Sean Green⁹, Barbara Beebe⁸, Casey Carr⁸, Michelle Fujimoto⁸, Annie Kathleen Brown⁸, Ann-Louise G Petersen⁸, Catherine McIntyre¹², Aman Siddiqui¹², Nadia Lepori-Bui¹², Katlin Villar¹², Kymhuynh Pham¹², Rachel Bove¹², Eric Musa¹², Warren D Reynolds⁸, Adam Kuo⁸, Snehit Prabhu⁸, Lindsey Rasmussen¹³, Timothy T Cornell¹³, Sonia Partap⁷, Paul G Fisher⁷, Cynthia J Campen⁷, Gerald Grant¹⁰, Laura Prolo¹⁰, Xiaobu Ye¹⁴, Bita Sahaf⁸, Kara L Davis^{9

8}, Steven A Feldman⁸, Sneha Ramakrishna^{15

16}, Crystal Mackall^{17

18

19

20}

Affiliations

¹ Department of Neurology and Neurological Sciences, Stanford University, Stanford, CA, USA. mmonje@stanford.edu.
² Division of Pediatric Hematology/Oncology/Stem Cell Transplant and Regenerative Medicine, Department of Pediatrics, Stanford University, Stanford, CA, USA. mmonje@stanford.edu.
³ Stanford Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University, Stanford, CA, USA. mmonje@stanford.edu.
⁴ Department of Neurosurgery, Stanford University, Stanford, CA, USA. mmonje@stanford.edu.
⁵ Department of Pathology, Stanford University, Stanford, CA, USA. mmonje@stanford.edu.
⁶ Howard Hughes Medical Institute, Stanford University, Stanford, CA, USA. mmonje@stanford.edu.
⁷ Department of Neurology and Neurological Sciences, Stanford University, Stanford, CA, USA.
⁸ Stanford Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University, Stanford, CA, USA.
⁹ Division of Pediatric Hematology/Oncology/Stem Cell Transplant and Regenerative Medicine, Department of Pediatrics, Stanford University, Stanford, CA, USA.
¹⁰ Department of Neurosurgery, Stanford University, Stanford, CA, USA.
¹¹ Division of Neuroradiology, Department of Radiology, Stanford University, Stanford, CA, USA.
¹² Cellular Therapy Facility, Stanford Health Care, Palo Alto, CA, USA.
¹³ Department of Pediatrics, Division of Pediatric Critical Care Medicine, Stanford University, Stanford, CA, US.
¹⁴ Department of Neurosurgery, Johns Hopkins School of Medicine, Baltimore, MD, USA.
¹⁵ Division of Pediatric Hematology/Oncology/Stem Cell Transplant and Regenerative Medicine, Department of Pediatrics, Stanford University, Stanford, CA, USA. ramakrs@stanford.edu.
¹⁶ Stanford Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University, Stanford, CA, USA. ramakrs@stanford.edu.
¹⁷ Division of Pediatric Hematology/Oncology/Stem Cell Transplant and Regenerative Medicine, Department of Pediatrics, Stanford University, Stanford, CA, USA. cmackall@stanford.edu.
¹⁸ Stanford Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University, Stanford, CA, USA. cmackall@stanford.edu.
¹⁹ Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA. cmackall@stanford.edu.
²⁰ Division of Stem Cell Transplantation and Cell Therapy, Department of Medicine, Stanford University, Stanford, CA, USA. cmackall@stanford.edu.

PMID: 39613972
PMCID: PMC11655351
DOI: 10.1038/s41586-024-08452-3

Published Erratum

Author Correction: Intravenous and intracranial GD2-CAR T cells for H3K27M⁺ diffuse midline gliomas

Michelle Monje et al. Nature. 2024 Dec.

. 2024 Dec;636(8043):E6.

doi: 10.1038/s41586-024-08452-3.

Authors

Affiliations

¹ Department of Neurology and Neurological Sciences, Stanford University, Stanford, CA, USA. mmonje@stanford.edu.
² Division of Pediatric Hematology/Oncology/Stem Cell Transplant and Regenerative Medicine, Department of Pediatrics, Stanford University, Stanford, CA, USA. mmonje@stanford.edu.
³ Stanford Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University, Stanford, CA, USA. mmonje@stanford.edu.
⁴ Department of Neurosurgery, Stanford University, Stanford, CA, USA. mmonje@stanford.edu.
⁵ Department of Pathology, Stanford University, Stanford, CA, USA. mmonje@stanford.edu.
⁶ Howard Hughes Medical Institute, Stanford University, Stanford, CA, USA. mmonje@stanford.edu.
⁷ Department of Neurology and Neurological Sciences, Stanford University, Stanford, CA, USA.
⁸ Stanford Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University, Stanford, CA, USA.
⁹ Division of Pediatric Hematology/Oncology/Stem Cell Transplant and Regenerative Medicine, Department of Pediatrics, Stanford University, Stanford, CA, USA.
¹⁰ Department of Neurosurgery, Stanford University, Stanford, CA, USA.
¹¹ Division of Neuroradiology, Department of Radiology, Stanford University, Stanford, CA, USA.
¹² Cellular Therapy Facility, Stanford Health Care, Palo Alto, CA, USA.
¹³ Department of Pediatrics, Division of Pediatric Critical Care Medicine, Stanford University, Stanford, CA, US.
¹⁴ Department of Neurosurgery, Johns Hopkins School of Medicine, Baltimore, MD, USA.
¹⁵ Division of Pediatric Hematology/Oncology/Stem Cell Transplant and Regenerative Medicine, Department of Pediatrics, Stanford University, Stanford, CA, USA. ramakrs@stanford.edu.
¹⁶ Stanford Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University, Stanford, CA, USA. ramakrs@stanford.edu.
¹⁷ Division of Pediatric Hematology/Oncology/Stem Cell Transplant and Regenerative Medicine, Department of Pediatrics, Stanford University, Stanford, CA, USA. cmackall@stanford.edu.
¹⁸ Stanford Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University, Stanford, CA, USA. cmackall@stanford.edu.
¹⁹ Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA. cmackall@stanford.edu.
²⁰ Division of Stem Cell Transplantation and Cell Therapy, Department of Medicine, Stanford University, Stanford, CA, USA. cmackall@stanford.edu.

PMID: 39613972
PMCID: PMC11655351
DOI: 10.1038/s41586-024-08452-3

No abstract available

PubMed Disclaimer

Erratum for

Intravenous and intracranial GD2-CAR T cells for H3K27M⁺ diffuse midline gliomas.
Monje M, Mahdi J, Majzner R, Yeom KW, Schultz LM, Richards RM, Barsan V, Song KW, Kamens J, Baggott C, Kunicki M, Rietberg SP, Lim AS, Reschke A, Mavroukakis S, Egeler E, Moon J, Patel S, Chinnasamy H, Erickson C, Jacobs A, Duh AK, Tunuguntla R, Klysz DD, Fowler C, Green S, Beebe B, Carr C, Fujimoto M, Brown AK, Petersen AG, McIntyre C, Siddiqui A, Lepori-Bui N, Villar K, Pham K, Bove R, Musa E, Reynolds WD, Kuo A, Prabhu S, Rasmussen L, Cornell TT, Partap S, Fisher PG, Campen CJ, Grant G, Prolo L, Ye X, Sahaf B, Davis KL, Feldman SA, Ramakrishna S, Mackall C. Monje M, et al. Nature. 2025 Jan;637(8046):708-715. doi: 10.1038/s41586-024-08171-9. Epub 2024 Nov 13. Nature. 2025. PMID: 39537919 Free PMC article. Clinical Trial.

Publication types

Actions

Grants and funding

R01 CA263500/CA/NCI NIH HHS/United States

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
- PubMed Central

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Author Correction: Intravenous and intracranial GD2-CAR T cells for H3K27M⁺ diffuse midline gliomas

Affiliations

Author Correction: Intravenous and intracranial GD2-CAR T cells for H3K27M⁺ diffuse midline gliomas

Authors

Affiliations

Erratum for

Publication types

Grants and funding

LinkOut - more resources

Full Text Sources